Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial.

Adam L CohenChristopher J AnkerBrett JohnsonLindsay M BurtDennis C ShrieveKaren SalzmanRandy JensenKen BoucherHoward Colman

Published in: Journal of neuro-oncology (2020)

Minocycline 400 mg orally twice a day with bevacizumab and reirradiation is well tolerated by physician and patient reported outcomes in people with gliomas that progress on bevacizumab.

Keyphrases

high grade
metastatic colorectal cancer
patient reported outcomes
low grade
primary care